ESPG extends lease with anchor tenant in Science Park “Lab City” until 2033

The European Science Park Group (ESPG), a real estate company specialising in science parks, has extended the lease agreement with the anchor tenant of the Science Park “Lab City” in Neu-Ulm until 31 December 2033. The tenant is a market-leading company in the pharmaceutical industry. The premises have GMP certification for the production of radiolabeled active ingredients. The leased floor space comprises around 12,000 square metres. In addition, a sustainable energy concept for the property is being drawn up and implemented in close consultation with the tenant.

Ralf Nöcker, CEO of ESPG AG, comments on the conclusion of the contract: “Our science parks offer optimal conditions for technological breakthroughs and strengthen Germany as a location for science. The conclusion of the contract once again confirms that this strategy is fully successful and underlines our capabilities as a science park investor and active asset manager. In addition, we have taken another important step in the implementation of our ESG strategy by optimising the property's energy concept.”

As part of the contract extension, the energy supply was switched to district heating. This makes biomass the Science Park's main energy source. Further measures to optimise the portfolio's ecological footprint are being planned - including the installation of photovoltaic modules. With the conclusion of the lease agreement, the average remaining term of the portfolio's leases (WAULT) is extended to 5.2 years.The ESPG portfolio currently comprises 16 science parks with a total area of more than 126,000 square metres. The concept of science parks is based on providing customised space to companies in the field of science and technology and supporting them on their growth path. As a rule, Science Parks are located in the immediate vicinity of universities, clinics and renowned research institutions and often reflect the focus of these academic institutions. This promotes the creation of synergies between the resident companies and supports the development of networks.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    The European Science Park Group (ESPG). (2023, June 02). ESPG extends lease with anchor tenant in Science Park “Lab City” until 2033. News-Medical. Retrieved on June 24, 2024 from https://www.news-medical.net/news/20230602/ESPG-extends-lease-with-anchor-tenant-in-Science-Park-e2809cLab-Citye2809d-until-2033.aspx.

  • MLA

    The European Science Park Group (ESPG). "ESPG extends lease with anchor tenant in Science Park “Lab City” until 2033". News-Medical. 24 June 2024. <https://www.news-medical.net/news/20230602/ESPG-extends-lease-with-anchor-tenant-in-Science-Park-e2809cLab-Citye2809d-until-2033.aspx>.

  • Chicago

    The European Science Park Group (ESPG). "ESPG extends lease with anchor tenant in Science Park “Lab City” until 2033". News-Medical. https://www.news-medical.net/news/20230602/ESPG-extends-lease-with-anchor-tenant-in-Science-Park-e2809cLab-Citye2809d-until-2033.aspx. (accessed June 24, 2024).

  • Harvard

    The European Science Park Group (ESPG). 2023. ESPG extends lease with anchor tenant in Science Park “Lab City” until 2033. News-Medical, viewed 24 June 2024, https://www.news-medical.net/news/20230602/ESPG-extends-lease-with-anchor-tenant-in-Science-Park-e2809cLab-Citye2809d-until-2033.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.